Literature DB >> 12762587

Differences in serotonin and dopamine metabolism in the rat brain in latent inhibition.

G F Molodtsova1.   

Abstract

Monoamine oxidase activity during deamination of serotonin and dopamine in the amygdaloid complex, hippocampus, striatum and prefrontal cortex of the brain was studied at different stages in the formation of latent inhibition, acquired by rats on the basis of a conditioned passive avoidance reaction. Latent inhibition is a behavioral phenomenon consisting of a worsening in learning using a stimulus when attention to this stimulus is quenched before acquisition of the conditioned response. At the stage of preliminary repeated presentation of the conditioned stimulus, serotonin metabolism was seen to change in the amygdaloid complex and striatum, while dopamine metabolism changed in the amygdaloid complex and hippocampus. Metabolic shifts in transmitter handling during quenching of attention to the stimulus occured in the opposite directions: the serotonin-deaminating activity of monoamine oxidase increased, while the dopamine-deaminating activity of the enzyme decreased. Unlike the reaction to the quenched stimulus, the latent inhibition effect, seen on testing the conditioned response after conditioning of the pre-exposed stimulus with unconditioned reinforcement, was accompanied by changes in serotoninergic activity only. High levels of serotonin deamination by monoamine oxidase were seen in the amygdaloid complex and striatum. In addition, there was a reduction in serotonin deamination in the prefrontal cortex specific for the stage of testing latent inhibition. At the same time, dopamine metabolism did not change in any of the brain structures studied in latent inhibition. These data lead to the conclusion that the latent inhibition effect may be based on increases in serotoninergic activity in subcortical brain structures--the amygdaloid complex and the striatum--induced by reactions to presentation of the quenched stimulus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762587     DOI: 10.1023/a:1022139028628

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  33 in total

1.  Latent inhibition is unaffected by direct dopamine agonists.

Authors:  J Feldon; A Shofel; I Weiner
Journal:  Pharmacol Biochem Behav       Date:  1991-02       Impact factor: 3.533

2.  Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions.

Authors:  L H Burns; L Annett; A E Kelley; B J Everitt; T W Robbins
Journal:  Behav Neurosci       Date:  1996-02       Impact factor: 1.912

3.  The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm.

Authors:  B A Ellenbroek; D A Knobbout; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

4.  Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity.

Authors:  L Lacroix; L M Broersen; J Feldon; I Weiner
Journal:  Behav Brain Res       Date:  2000-01       Impact factor: 3.332

5.  Disruption of habituation by caudate nuclear stimulation in the rat.

Authors:  S A Deadwyler; E J Wyers
Journal:  Behav Biol       Date:  1972-02

6.  Forebrain monoamines and associative learning: I. Latent inhibition and conditioned inhibition.

Authors:  J F Lorden; E J Rickert; D W Berry
Journal:  Behav Brain Res       Date:  1983-08       Impact factor: 3.332

7.  The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat.

Authors:  H J Cassaday; H Hodges; J A Gray
Journal:  J Psychopharmacol       Date:  1993-01       Impact factor: 4.153

8.  Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.

Authors:  P R Solomon; A Crider; J W Winkelman; A Turi; R M Kamer; L J Kaplan
Journal:  Biol Psychiatry       Date:  1981-06       Impact factor: 13.382

9.  MDL 73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the rat.

Authors:  P M Moran; P C Moser
Journal:  Pharmacol Biochem Behav       Date:  1992-07       Impact factor: 3.533

Review 10.  Neural substrates of latent inhibition: the switching model.

Authors:  I Weiner
Journal:  Psychol Bull       Date:  1990-11       Impact factor: 17.737

View more
  1 in total

1.  Reduced activity at the 5-HT(2C) receptor enhances reversal learning by decreasing the influence of previously non-rewarded associations.

Authors:  S R O Nilsson; T L Ripley; E M Somerville; P G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.